Clinical Trial Update: CAR-T Immunomonitoring in Multiple Myeloma (CART I5M) [NA]

View source ↗

Summary

This clinical trial entry CART I5M is evaluating CAR-T immunomonitoring in multiple myeloma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Poitiers University Hospital | Conditions: Multiple Myeloma (MM) | NA | Status: RECRUITING